Feasibility of an Artificial Intelligence Phone Call After Cataract Surgery

Uptown Eye Specialists

Status: Not yet enrolling

Conditions: Cataract

Treatments: Device: DORA AI

Study type: Interventional

Funder types: Other

Identifiers

NCT05766722

UptownEye3

Details and patient eligibility

About

To analyze the evidence for clinical safety, usability, acceptability, satisfaction, appropriateness, and cost-effectiveness of Dora for recognizing patients who require additional in-person evaluation post cataract surgery. To assess Dora's sensitivity and specificity in cataract surgery management To determine what can be learnt to enhance AI technology in the field of ophthalmology especially when working with culturally diverse patients such as Punjabi and Chinese speaking patients.

Full description

Background:

Cataract is defined as the degradation of the optical quality of the crystalline lens that affects vision and is the current leading cause of blindness worldwide. AI is set to revolutionize post-cataract surgery management by enhancing automation, increasing effectiveness, decreasing burdens placed on patients and the health care system. Ultimately, using AI-enabled automation could enhance patient management during and post cataract surgery.Cataract post-operative contact will be delivered by Dora agent, a natural language AI assistant.

Aim and objective:

Dora is a clinically safe, usable, appropriate, satisfactory and cost-effective AI technology for recognizing patients who require additional evaluation post cataract surgery.

Enrollment: 250 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who are undergoing uncomplicated cataract surgery at a high volume surgical centre.

Exclusion criteria

• clinically significant complications during surgery that require more than the standard postop treatment or follow-up

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

250 participants in 1 patient group

All patients 18 years old or older undergoing uncomplicated cataract surgery.

Experimental group

Treatment:

Device: DORA AI